The largest database of trusted experimental protocols

Onetouch ultraeasy blood glucose monitoring system

Manufactured by LifeScan
Sourced in United States

The OneTouch UltraEasy Blood Glucose Monitoring System is a device used to measure blood glucose levels. It provides a simple and convenient way to monitor blood sugar for individuals who require regular glucose testing.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using onetouch ultraeasy blood glucose monitoring system

1

Fasting Blood Glucose and Insulin Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mice were fasted for 6 h in the morning before blood glucose measurements. Blood glucose was measured through the tail vein by the use of the OneTouch UltraEasy Blood Glucose Monitoring System (Lifescan, Milpitas, CA, USA). Serum insulin levels were determined by a murine enzyme-linked immunosorbent assay kit (Shanghai Enzyme-linked Biotechnology Co., Shanghai, China). Whole blood was withdrawn from the orbital sinus, and plasma was separated by centrifugation at 3400 rpm for 15 min in EDTA-K2-treated microtubes (Kangjian Medical, China).
+ Open protocol
+ Expand
2

Metabolic Characterization of Fasted Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were fasted for 6 h (9:00 a.m. ~ 15:00 p.m.) before blood glucose measurements. Blood glucose was measured through the tail vein using the OneTouch UltraEasy Blood Glucose Monitoring System (Lifescan, Milpitas, CA, USA). Serum insulin levels were determined by a murine enzyme-linked immunosorbent assay (Shanghai Enzyme-linked Biotechnology Co., Shanghai, China). Whole blood was withdrawn from the eyeball, and plasma was separated by centrifugation at 3,000 rpm for 15 min in EDTA-K2-treated microtubes (Kangjian Medical, China). The homeostatic model assessment (HOMA) was used to quantify insulin resistance (HOMA-IR) and β cell function (%B). HOMA-IR was calculated using the following formula: HOMA-IR = (fasting glucose × fasting insulin)/22.5. HOMA %B was calculated using the following formula: HOMA-%B = (20 × fasting insulin)/(fasting glucose - 3.5) %.
+ Open protocol
+ Expand
3

Fasted Mice Blood Glucose and Insulin Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were fasted for 6 h (9:00 a. m ∼ 15:00 p. m) before blood glucose measurements. Blood glucose was measured through tail vein using the OneTouch UltraEasy Blood Glucose Monitoring System (Lifescan, Milpitas, CA, USA). Serum insulin levels were measured by mouse enzyme-linked immunosorbent assay (Shanghai Enzyme-linked Biotechnology Co., Shanghai, China), according to manufacturer's instructions. Whole blood was withdrawn by removing eyeballs, and plasma was separated by centrifugation at 3,000 rpm for 15 min in EDTA-K2-treated microtubes (Kangjian Medical, Jiangsu, China). The homeostatic model assessment (HOMA) was the method used to quantify insulin resistance (HOMA-IR) and beta-cell function (%B). HOMA-IR was calculated using the following formula: HOMA-IR = (fasting glucose × fasting insulin)/22.5. HOMA %B was calculated using the following formula: HOMA-%B = (20 x fasting insulin)/(fasting glucose - 3.5)%.
+ Open protocol
+ Expand
4

Glucose Tolerance and Insulin Sensitivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mice were fasted for 6 h with free access to water the morning before OGTTs and insulin tolerance tests (ITTs). Blood glucose was measured through the tail vein using the OneTouch UltraEasy Blood Glucose Monitoring System (Lifescan, Milpitas, CA, USA) 0, 15, 30, 60, and 120 min after an oral gavage of d-glucose (1.0 g/kg) at postoperative weeks 4 and 14. Blood glucose was measured 0, 15, 30, 60, and 120 min after intraperitoneal injection with human insulin (0.8 U/kg Humulin R; Novo Nordisk) at postoperative week 15. In additional experiments, fasted mice were intraperitoneally injected with sterile saline (0.9% NaCl) with or without the GLP-1R antagonist Ex-9 (50 μg; Tocris Biosciences, Bristol, UK) 120 min before the OGTT in each group at postoperative weeks 4 and 14.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!